ZOTIDE ONE PEN

Zotide One 600mcg Injection contains Teriparatide, a synthetic form of parathyroid hormone (PTH), and is primarily used to treat osteoporosis in individuals at high risk of fractures. Osteoporosis is a condition characterized by loss of bone mass and strength, leading to an increased risk of bone fractures, particularly in the spine, hip, and wrist. Zotide One helps combat this by stimulating the activity of osteoblasts (bone-building cells), promoting the formation of new bone tissue, and enhancing bone mineral density.

This medication is especially beneficial for patients who have already suffered fractures, as it has been found to speed up bone healing. It aids in the development of the callus, a temporary bone structure that forms during the early stages of healing, ultimately contributing to faster and more complete recovery.

However, Zotide One 600mcg Injection is contraindicated in individuals with known hypersensitivity to Teriparatide or any of its ingredients. It should also be avoided in patients with a history of bone cancers, such as osteosarcoma, or in those with bone metastases from other cancers. Additionally, patients who have undergone skeletal radiation therapy should not use this medication, as it may increase the risk of developing osteosarcoma, a rare but serious bone tumor.

As with any medication, it is important to inform your healthcare provider about your complete medical history and any other medications or treatments you are receiving before beginning therapy with Zotide One.